Rizatriptan Benzoate Tablet, Orally Disintegrating
Product Images NDC 68462-467

This is a description of medication information for Rizatriptan Benzoate Orally Disintegrating Tablets USP. Each tablet contains 1453 mg of Rizatriptan Benzoate, USP equivalent to 10 mg Rizatriptan. The medication is manufactured by Glenmark and each pack contains 18 tablets (6 cartons, each containing 3 orally disintegrating tablets). It is important to note that the medication contains phenylalanine (a component of aspartame) which is 49 mg per 10 mg orally disintegrating tablet. The usual dosage and prescribing information can be found in the accompanying prescribing formition. The medication should be stored at room temperature, 20°C to 25°C (68°F to 77°F), with excursions permitted b 15°C to 30°C (59°F to 86°F) as per USP (Controlled Room Temperature). Further questions can be directed to 1-888-721-7115.*

This appears to be a chart displaying the effectiveness of different dosages of a medication called Rizatriptan benzoate in treating symptoms over a period of time. The chart compares the effectiveness of a placebo with two dosages of Rizatriptan benzoate (5mg and 10mg) at different time intervals after administering the medication. The percentages on the y-axis likely represent the percentage of patients who experienced relief of symptoms at each time interval.*

This appears to be a chart or graph showing estimated probability of remedication or rescue for a placebo and two medications (zatriptan benzoate ODT 5 mg and rizatriptan benzoate ODT 10 mg) as a function of hours post-dose. The probability ranges from 0-100% with 10% increments. It is not clear what condition or ailment is being treated.*